US Stock MarketDetailed Quotes

Compass Therapeutics (CMPX)

Watchlist
  • 5.700
  • -0.100-1.72%
Close Jan 16 16:00 ET
  • 5.730
  • +0.030+0.53%
Post 20:01 ET
1.01BMarket Cap-12.67P/E (TTM)

Compass Therapeutics (CMPX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.83%-10.85M
-10.02%-11.83M
4.90%-13.21M
-10.43%-44.86M
25.84%-9.16M
-86.61%-11.05M
-6.34%-10.75M
-13.57%-13.89M
-19.03%-40.62M
-16.10%-12.35M
Net income from continuing operations
-36.07%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.17%-10.48M
-15.94%-13.08M
-37.64%-10.79M
-8.33%-42.49M
-15.71%-13.42M
Depreciation and amortization
-20.22%371K
-21.24%367K
-21.38%364K
-7.25%1.75M
-23.29%359K
-0.21%465K
-1.89%466K
-3.74%463K
-0.74%1.89M
-3.31%468K
Change In working capital
173.59%2.18M
986.36%5.02M
110.04%521K
-42.43%-4.14M
1,917.44%3.54M
-208.04%-2.96M
376.29%462K
6.42%-5.19M
-130.25%-2.91M
-454.55%-195K
-Change in prepaid assets
154.33%4.02M
226.21%6.26M
-485.58%-5.48M
-171.83%-4.86M
-136.89%-539K
-56.55%1.58M
-359.57%-4.96M
-274.40%-936K
220.94%6.76M
123.45%1.46M
-Change in payables and accrued expense
60.20%-1.81M
-120.94%-1.2M
258.96%6.26M
122.82%1.93M
446.21%4.66M
-655.91%-4.54M
479.04%5.75M
21.36%-3.94M
-255.95%-8.47M
-120.49%-1.35M
-Change in other current liabilities
-840.00%-37K
87.38%-41K
20.94%-253K
-1.25%-1.22M
-86.13%-577K
101.66%5K
-9.06%-325K
-9.22%-320K
-9.07%-1.2M
-9.15%-310K
Cash from discontinued investing activities
Operating cash flow
1.83%-10.85M
-10.02%-11.83M
4.90%-13.21M
-10.43%-44.86M
25.84%-9.16M
-86.61%-11.05M
-6.34%-10.75M
-13.57%-13.89M
-19.03%-40.62M
-16.10%-12.35M
Investing cash flow
Cash flow from continuing investing activities
-427.92%-95.16M
-198.10%-6.36M
382.70%11.59M
73.45%46.77M
143.43%15.37M
70.20%29.02M
1,071.96%6.48M
-196.02%-4.1M
117.83%26.97M
113.54%6.31M
Net PPE purchase and sale
84.09%-7K
--0
---18K
-46.67%-44K
--0
-340.00%-44K
--0
--0
16.67%-30K
83.33%-9K
Net investment purchase and sale
-427.40%-95.15M
-198.10%-6.36M
383.14%11.61M
73.42%46.82M
143.08%15.37M
70.36%29.06M
1,088.26%6.48M
-196.02%-4.1M
117.86%27M
113.57%6.32M
Cash from discontinued investing activities
Investing cash flow
-427.92%-95.16M
-198.10%-6.36M
382.70%11.59M
73.45%46.77M
143.43%15.37M
70.20%29.02M
1,071.96%6.48M
-196.02%-4.1M
117.83%26.97M
113.54%6.31M
Financing cash flow
Cash flow from continuing financing activities
6,468,150.00%129.36M
0
-104.68%-815K
490.73%17.34M
40.51%-94K
-109.52%-2K
-99.97%1K
42,419.51%17.43M
-96.13%2.94M
-100.21%-158K
Net common stock issuance
--138M
--0
--0
479.43%18.11M
--0
--0
--0
--18.11M
-95.90%3.13M
--0
Proceeds from stock option exercised by employees
----
----
----
--0
--0
--0
--0
--0
313.33%62K
--0
Net other financing activities
-431,800.00%-8.64M
--0
-19.85%-815K
-206.32%-775K
40.51%-94K
---2K
--1K
---680K
48.89%-253K
---158K
Cash from discontinued financing activities
Financing cash flow
6,468,150.00%129.36M
--0
-104.68%-815K
490.73%17.34M
40.51%-94K
-109.52%-2K
-99.97%1K
42,419.51%17.43M
-96.13%2.94M
-100.21%-158K
Net cash flow
Beginning cash position
20.72%23.42M
73.44%41.62M
79.45%44.05M
-30.67%24.23M
22.82%37.37M
0.65%19.4M
-11.22%23.99M
-29.75%24.55M
-75.82%34.95M
84.61%30.43M
Current changes in cash
30.01%23.36M
-326.04%-18.19M
-339.53%-2.44M
279.65%19.26M
198.64%6.11M
61.15%17.97M
44.90%-4.27M
93.00%-554K
90.22%-10.72M
-133.57%-6.2M
End cash Position
25.18%46.78M
20.72%23.42M
73.44%41.62M
79.47%43.48M
79.47%43.48M
22.82%37.37M
0.65%19.4M
-11.22%23.99M
-30.67%24.23M
-30.67%24.23M
Free cash flow
2.15%-10.86M
-10.02%-11.83M
4.77%-13.23M
-10.46%-44.9M
25.89%-9.16M
-87.04%-11.1M
-6.22%-10.75M
-13.57%-13.89M
-18.38%-40.65M
-15.60%-12.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.83%-10.85M-10.02%-11.83M4.90%-13.21M-10.43%-44.86M25.84%-9.16M-86.61%-11.05M-6.34%-10.75M-13.57%-13.89M-19.03%-40.62M-16.10%-12.35M
Net income from continuing operations -36.07%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.17%-10.48M-15.94%-13.08M-37.64%-10.79M-8.33%-42.49M-15.71%-13.42M
Depreciation and amortization -20.22%371K-21.24%367K-21.38%364K-7.25%1.75M-23.29%359K-0.21%465K-1.89%466K-3.74%463K-0.74%1.89M-3.31%468K
Change In working capital 173.59%2.18M986.36%5.02M110.04%521K-42.43%-4.14M1,917.44%3.54M-208.04%-2.96M376.29%462K6.42%-5.19M-130.25%-2.91M-454.55%-195K
-Change in prepaid assets 154.33%4.02M226.21%6.26M-485.58%-5.48M-171.83%-4.86M-136.89%-539K-56.55%1.58M-359.57%-4.96M-274.40%-936K220.94%6.76M123.45%1.46M
-Change in payables and accrued expense 60.20%-1.81M-120.94%-1.2M258.96%6.26M122.82%1.93M446.21%4.66M-655.91%-4.54M479.04%5.75M21.36%-3.94M-255.95%-8.47M-120.49%-1.35M
-Change in other current liabilities -840.00%-37K87.38%-41K20.94%-253K-1.25%-1.22M-86.13%-577K101.66%5K-9.06%-325K-9.22%-320K-9.07%-1.2M-9.15%-310K
Cash from discontinued investing activities
Operating cash flow 1.83%-10.85M-10.02%-11.83M4.90%-13.21M-10.43%-44.86M25.84%-9.16M-86.61%-11.05M-6.34%-10.75M-13.57%-13.89M-19.03%-40.62M-16.10%-12.35M
Investing cash flow
Cash flow from continuing investing activities -427.92%-95.16M-198.10%-6.36M382.70%11.59M73.45%46.77M143.43%15.37M70.20%29.02M1,071.96%6.48M-196.02%-4.1M117.83%26.97M113.54%6.31M
Net PPE purchase and sale 84.09%-7K--0---18K-46.67%-44K--0-340.00%-44K--0--016.67%-30K83.33%-9K
Net investment purchase and sale -427.40%-95.15M-198.10%-6.36M383.14%11.61M73.42%46.82M143.08%15.37M70.36%29.06M1,088.26%6.48M-196.02%-4.1M117.86%27M113.57%6.32M
Cash from discontinued investing activities
Investing cash flow -427.92%-95.16M-198.10%-6.36M382.70%11.59M73.45%46.77M143.43%15.37M70.20%29.02M1,071.96%6.48M-196.02%-4.1M117.83%26.97M113.54%6.31M
Financing cash flow
Cash flow from continuing financing activities 6,468,150.00%129.36M0-104.68%-815K490.73%17.34M40.51%-94K-109.52%-2K-99.97%1K42,419.51%17.43M-96.13%2.94M-100.21%-158K
Net common stock issuance --138M--0--0479.43%18.11M--0--0--0--18.11M-95.90%3.13M--0
Proceeds from stock option exercised by employees --------------0--0--0--0--0313.33%62K--0
Net other financing activities -431,800.00%-8.64M--0-19.85%-815K-206.32%-775K40.51%-94K---2K--1K---680K48.89%-253K---158K
Cash from discontinued financing activities
Financing cash flow 6,468,150.00%129.36M--0-104.68%-815K490.73%17.34M40.51%-94K-109.52%-2K-99.97%1K42,419.51%17.43M-96.13%2.94M-100.21%-158K
Net cash flow
Beginning cash position 20.72%23.42M73.44%41.62M79.45%44.05M-30.67%24.23M22.82%37.37M0.65%19.4M-11.22%23.99M-29.75%24.55M-75.82%34.95M84.61%30.43M
Current changes in cash 30.01%23.36M-326.04%-18.19M-339.53%-2.44M279.65%19.26M198.64%6.11M61.15%17.97M44.90%-4.27M93.00%-554K90.22%-10.72M-133.57%-6.2M
End cash Position 25.18%46.78M20.72%23.42M73.44%41.62M79.47%43.48M79.47%43.48M22.82%37.37M0.65%19.4M-11.22%23.99M-30.67%24.23M-30.67%24.23M
Free cash flow 2.15%-10.86M-10.02%-11.83M4.77%-13.23M-10.46%-44.9M25.89%-9.16M-87.04%-11.1M-6.22%-10.75M-13.57%-13.89M-18.38%-40.65M-15.60%-12.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More